Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
388 JPY | -0,51% | -11,01% | -25,67% |
Vakgebied
Aantal werknemers: 67
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drug Discovery Support
56,5
%
| 1 101 | 79,4 % | 918 | 56,5 % | -16,58% |
Drug Discovery
43,5
%
| 286 | 20,6 % | 708 | 43,5 % | +147,39% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
North America
69,8
%
| 855 | 61,7 % | 1 135 | 69,8 % | +32,67% |
Japan
13,7
%
| 219 | 15,8 % | 223 | 13,7 % | +2,08% |
China
7,9
%
| 203 | 14,6 % | 129 | 7,9 % | -36,57% |
Europe
6,9
%
| 72 | 5,2 % | 113 | 6,9 % | +56,84% |
Other
1,6
%
| 38 | 2,7 % | 26 | 1,6 % | -30,48% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
President | 75 | 10-04-03 | |
Emi Yamamoto
ADM | Chief Administrative Officer | 53 | 01-01-04 |
Masaaki Sawa
CTO | Chief Tech/Sci/R&D Officer | 53 | 01-01-07 |
Akinori Arimura
BRD | Director/Board Member | 61 | 01-07-18 |
Norio Aikawa
BRD | Director/Board Member | 75 | 10-04-03 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Teruo Takayanagi
BRD | Director/Board Member | 77 | 01-03-15 |
Tsuguo Ogasawara
BRD | Director/Board Member | 84 | 01-03-05 |
President | 75 | 10-04-03 | |
Norio Aikawa
BRD | Director/Board Member | 75 | 10-04-03 |
Atsuo Arita
BRD | Director/Board Member | 80 | 01-03-04 |
Takao Matsui
BRD | Director/Board Member | 68 | 01-03-19 |
Masaaki Sawa
CTO | Chief Tech/Sci/R&D Officer | 53 | 01-01-07 |
Emi Yamamoto
ADM | Chief Administrative Officer | 53 | 01-01-04 |
Akinori Arimura
BRD | Director/Board Member | 61 | 01-07-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 17 156 900 | 15 400 276 ( 89,76 %) | 7 124 ( 0,0415 %) | 89,76 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
CARNA BIOSCIENCES, INC. 0.04% | 7 100 | 0.04% | 19 446 $ |
Bedrijfsgegevens
Carna Biosciences, Inc.
Kobe Biomedical Creation Center, 3/F 1-5-5 Minatojima-Minamimachi
650-0047, Kobe
+
http://www.carnabio.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,67% | 42,4 mln. | |
+67,53% | 63,85 mld. | |
-0,77% | 41,83 mld. | |
+45,66% | 40,65 mld. | |
-10,72% | 27,12 mld. | |
+13,30% | 26,52 mld. | |
-22,79% | 18,69 mld. | |
+4,70% | 12,73 mld. | |
+24,10% | 12,11 mld. | |
+27,41% | 12,07 mld. |
- Beurs
- Aandelen
- Koers 4572
- Onderneming Carna Biosciences, Inc.